AC Immune SA (ACIU) earnings
Quarterly and annual ACIU reports and results, each read against the price at its own news timestamp. Back to the ACIU overview →
2 measured ACIU earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update | Press release | +3.98% | +0.28% | |
| AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update | Press release | -4.02% | -1.79% |
Keep exploring
More ACIU: analyst actions → · SEC filings → · ACIU overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | 198 | -0.18% | 44% |
| Stereotaxis, Inc. (STXS) | 197 | +0.11% | 51% |
| Daxor Corporation - Closed End Fund (DXR) | 196 | 0.00% | 49% |
| GENMAB A/S DKK (GNMSF) | 196 | 0.00% | 23% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.